Pharma-Bio Serv, Inc.
PBSV
$0.4998
$0.000.00%
OTC PK
| 01/31/2025 | 10/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 5.91% | -3.51% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 5.91% | -3.51% | |||
| Cost of Revenue | 6.01% | -9.88% | |||
| Gross Profit | 5.71% | 14.35% | |||
| SG&A Expenses | -2.32% | -13.42% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 3.06% | -11.16% | |||
| Operating Income | 40.17% | 59.64% | |||
| Income Before Tax | 165.54% | 94.90% | |||
| Income Tax Expenses | 103.55% | -263.16% | |||
| Earnings from Continuing Operations | -47.20% | 105.21% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -47.20% | 105.21% | |||
| EBIT | 40.17% | 59.64% | |||
| EBITDA | 44.13% | 60.71% | |||
| EPS Basic | -42.86% | 105.19% | |||
| Normalized Basic EPS | 175.00% | 94.94% | |||
| EPS Diluted | -42.86% | 105.00% | |||
| Normalized Diluted EPS | 175.00% | 94.94% | |||
| Average Basic Shares Outstanding | -0.06% | 0.04% | |||
| Average Diluted Shares Outstanding | -0.05% | 0.04% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||